Marci Nanis
Vice President of Investor Relations and Corporate Affairs
Replay available
Palvella Therapeutics, Inc. (PVLA) Q2 2026 Earnings Call
Palvella Therapeutics, Inc. (NASDAQ: PVLA) Q2 2026 earnings conference call, held 2026-08-04. Replay captured from the company's public earnings webcast.
Hosted by
Featured presenters
Wes Kaupinen
Founder and Chief Executive Officer
Dr. Jeff Martini
Chief Scientific Officer
Matt Korenberg
Chief Financial Officer
Investor webinar replay
Watch the replay and follow the connected company analysis, news, and investor updates for Palvella Therapeutics, Inc..
Replay transcript excerpt
WEBVTT 00:00:00.287 -- 00:00:05.528 Good day, and thank you for standing by. Welcome to the Povella Therapeutics Second Quarter 00:00:05.528 -- 00:00:10.670 2026 Financial Results Conference Call. At this time, all participants are in a listen-only 00:00:10.670 -- 00:00:15.651 mode. After the speaker's presentation, there will be a question and answer session. 00:00:15.651 -- 00:00:20.332 To ask a question during the session, you will need to press star 11 on your telephone. 00:00:20.332 -- 00:00:24.053 You will then hear an automated message advising your hand is raised. 00:00:24.053 -- 00:00:27.543 To withdraw your question, please press star 11 again. 00:00:27.543 -- 00:00:31.285 Please be advised that today's conference is being recorded. 00:00:31.285 -- 00:00:36.507 I would now like to hand the conference over to your first speaker today, Marci Nanis, 00:00:36.507 -- 00:00:40.609 Vice President of Investor Relations and Corporate Affairs. 00:00:41.170 -- 00:00:45.572 Thank you, Operator. Good morning, and thank you for joining the Paul Vella Therapeutics 00:00:45.572 -- 00:00:50.230 Second Quarter 2026 Financial Results and Corporate Update Call. 00:00:50.230 -- 00:00:54.214 As a reminder, our press release detailing today's announcements can be found in the 00:00:54.214 -- 00:00:58.656 investor section of our website at www.palvellatx.com. 00:01:00.079 -- 00:01:05.203 On today's call, I am joined by Wes Kaupinen, our founder and chief executive officer, 00:01:05.203 -- 00:01:10.388 Dr. Jeff Martini, our chief scientific officer, and Matt Korenberg, our chief financial 00:01:10.388 -- 00:01:15.668 officer. Before we begin, Please note that today's remarks may include forward-looking 00:01:15.668 -- 00:01:20.350 statements regarding our development programs, regu...